Dopastatin Uses, Dosage, Side Effects and more
Dopastatin is under investigation in clinical trial NCT04335357 (TBR-760 in Adult Patients With Non-functioning Pituitary Adenomas).
| Attribute | Details |
|---|---|
| Trade Name | Dopastatin |
| Generic | Dopastatin |
| Type | |
| Formula | C86H116N16O12S4 |
| Weight | Average: 1694.21 Monoisotopic: 1692.784147935 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
